On Tuesday, WoLF joined over fifty clinicians and researchers in ten different countries and multiple organizations in demanding that the Food and Drug Administration (FDA) take action against the off-label use of puberty blockers in children.

WoLF is disappointed to learn that the U.S. Supreme Court has declined to hear the case of Tingley v. Ferguson. The case centered around Washington state's SB 5722, a law that infringes on the rights of therapists and patients by mandating 'affirmation-only' therapy for minors with gender dysphoria.

The decision finally acknowledged what feminists have been saying for years: “Transgender” identification is neither an immutable status nor an oppressed class

Dangerous puberty blockers like Lupron are being prescribed to minors without FDA oversight - Act now to protect more children from harm!

A bill in the California state senate would make it easier for individuals to use a woman for surrogacy by forcing healthcare plans to offer coverage for surrogacy as “infertility” treatment.

A bill currently making its way through the California legislature, AB 957, amends state family law to make not “affirming” a child's claimed “gender identity” child abuse.

"I felt really guilty that this woman just had my baby. Then I take the baby and go to another room, and you're separated," Kardashian said. "I felt it was such a transactional experience."

Washington State’s SB 5722 would require licensed therapists to use “affirmation-only” therapy and effectively ban mental health care for detransitioners

WoLF endorses California’s AB 1501, which would require businesses to verify that porn consumers are 18 years or older.

On January 26, 2023, WoLF submitted written testimony in support of Montana Senate Bill 99, the Youth Health Protection Act.

Despite its stated dedication to “the health of all children,” the AAP is leading the sterilization of a generation.

On January 24, WoLF submitted written testimony in support of three bills in Missouri to protect children from life-altering medical interventions.

Given the way some trans-identified people discuss hormones and surgeries as a ticket to their idealized lives in ways that extend beyond the direct cosmetic changes, it seems likely that displaced meaning is motivating some people to “transition.”

WoLF educated the NIH about research opportunities and needs related to “gender-affirming care,” including the physical and psychological impacts on female patients. 

The proposed HHS regulations will redefine discrimination on the basis of sex, expanding it so that “gender identity” will be considered a form of sex-based discrimination. If HHS is allowed to include “gender identity” as a form of sex-based discrimination, healthcare providers in a wide variety of government programs will be forced to provide “gender affirming” medical interventions to patients.

Last week, the 8th US Circuit Court of Appeals ruled against WoLF’s position in the Arkansas SAFE Act case, Brandt v. Rutledge.